ABIONYX PHARMA earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €-0.16 | €-0.16 | 2026-06-19T16:34:53Z |
| 2024 | 2024-12-31 | €-0.13 | €-0.13 | 2026-06-19T16:34:53Z |
Revenue & profit (EUR)
| Concept | 2025 | 2024 |
|---|---|---|
| Revenue | €4.1M | €4.6M |
| Profit for the year | -€5.5M | -€4.4M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in ABIONYX PHARMA's ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.